Cleared Special

K100362 - CAMBRIDGE HEART OEM

K100362 is an FDA 510(k) clearance for CAMBRIDGE HEART OEM, manufactured by Cambridge Heart, Inc.. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Special 510(k) pathway after a 61-day FDA review.

K100362 · Cambridge Heart, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2010
Decision
61d
Days
Class 2
Risk

K100362 is an FDA 510(k) clearance for the CAMBRIDGE HEART OEM. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Cambridge Heart, Inc. (South West Ranches, US). The FDA issued a Cleared decision on April 14, 2010 after a review of 61 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Low regulatory complexity profile. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Cambridge Heart, Inc. devices

FDA 510(k) Submission Details - K100362

510(k) Number K100362 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 12, 2010
Decision Date April 14, 2010
Days to Decision 61 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
64d faster than avg
Panel avg: 125d · This submission: 61d
Pathway characteristics
Modification to existing cleared device.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 294
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K100362.
ENSITE VELOCITY SYSTEM REFERRED TO ENSITE VELOCITY SYSTEM WITH POSITIONAL REFERENCE TOOL (PRT)
K101667 · St Jude Medical · Jul 2010
CARTO XP EP NAVIGATION SYSTEM, VERSION 10
K093566 · Biosense Webster, Inc. · Jun 2010
ENSITE VELOCITY SYSTEM, MODEL EE3000
K101419 · St Jude Medical · Jun 2010
ENSITE VELOCITY SYSTEM V1.3
K093942 · St Jude Medical · Feb 2010
ODYSSEY WORKSTATION
K093092 · Stereotaxis, Inc. · Jan 2010
MARS HOLTER ANALYSIS WORKSTATION
K093141 · Ge Medical Systems Information Technologies · Dec 2009